IJCS | Volume 33, Nº3, May / June 2020

214 3. Cardoso F, Polonia J, Santos A, Silva-Carvalho J, Ferreira-de-Almeida J. Low-dose oral contraceptives and 24-hour ambulatory blood pressure. Int J Gynaecol Obstet. 1997;59(3):237–43. 4. Abrahão SB, Mion Jr D. Hipertensão arterial e contraceptivos orais. Rev Bras Hipertens. 2000;7(4):392-5. 5. Gordon MS, Chin WW, Shupnik MA. Regulation of angiotensinogen gene expression by estrogen. J Hypertens.1992;10(4):361-6. 6. Liu H, Yao J, Wang W, Zhang D. Association between duration of oral contraceptive use and risk of hypertension: a meta-analysis. J Clin Hypertens. 2017;19(10):1032–41. 7. Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. J Intern Med. 2008;264(3):224-36. 8. Suthipongse W, Taneepanichskul S. An open-label randomized comparative study of oral contraceptives between medications containing 3 mg drospirenone/30 microgethinylestradiol and 150 microglevonogestrel/30 microgethinylestradiol in Thai women. Contraception. 2004;69(1):23–6. 9. Ribeiro CCM, ShimoAKK, Lopes MHBM, Lamas JLT. Effects of different hormonal contraceptives in women's blood pressure values. Rev Bras Enferm. 2018;71(supl. 3):1537-43. 10. Petto J, Pereira LS, Santos ACN, Giesta BA, Melo TA, Ladeia AMT. Subclinical inflammation in women taking oral contraceptives.. Rev Bras Cardiol. 2013;26(6):465-71. 11. Parikh NI, Gona P, Larson MG, Wang TJ, Newton-Cheh C, Levy D, et al. Plasma renin and risk of cardiovascular disease and mortality: the Framingham Heart Study. Eur Heart J. 2007;28(21):2644-52. 12. Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. J Intern Med. 2008;264(3):224-36. 13. Wang XL, Rainwater DL, VandeBerg JF, Mitchell BD, Mahaney MC. Genetic contributions to plasma total antioxidant activity. Arterioscler Thromb Vasc Biol. 2001;21(7):1190-5. 14. Casazza GA, Suh SH, Miller BF, Navazio FM, Brooks GA. Effects of oral contraceptives on peak exercise capacity. JAppl Physiol. 2002;93(5):1698- 702. 15. Sedeek M, Hebert RL, Ketmedy CR, Burns KD, Touyz RM. Molecular mechanisms of hypertension: role of Nox family NADPH oxidases. Curr Opin Nephrol Hypertens. 2009;18(2):122-7. 16. Taniyama Y, Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension. 2003;42(6):1075-81. 17. Kelly DJ, Cox AJ, Gow RM, Zhang Y, Kemp BE, Gilbert RE. Platelet- derived growth factor receptor transactivation mediates the trophic effects of angiotensin II in vivo. Hypertension. 2004;44(2):195-202. 18. Santos ACN, Petto J, Oliveira FTO, Diogo DP, Ladeia AMT. C-Reactive Protein in Oral Contraceptive Users: Related Factors and Cardiovascular Risk. Int J Cardiovasc Sci. 2016;29(4):320-5. 19. Usselman CW, Luchyshyn TA, Gimon TI, Nielson CA, Van Uum SH, Shoemaker JK. Hormone phase dependency of neural responses to chemoreflex-driven sympathoexcitation in young women using hormonal contraceptives. J Appl Physiol. 2013;115(10):1415-22. Oliveira et al. Plasma renin and use of oral contraceptives Int J Cardiovasc Sci. 2020; 33(3):208-214 Original Article This is an open-access article distributed under the terms of the Creative Commons Attribution License